Benzoxathiolone-Thiazolidinone Hybrids: A New Class in the Search for Anticancer Agents
The study suggests these benzoxathiolone-thiazolidinone hybrids could be promising lead compounds for developing new anticancer agents targeting leukemia.
Authors
- Luína Benevides Lima (ORCID: https://orcid.org/0000-0001-6503-8657)
- Raquel Carvalho Montenegro (ORCID: https://orcid.org/0000-0002-3861-293X)
- Ligia S. da Silveira Pinto
- Felipe Pantoja Mesquita (ORCID: https://orcid.org/0000-0002-6576-0161)
- T.R.A. Vasconcelos (ORCID: https://orcid.org/0000-0002-3421-191X)
- Pedro Filho Noronha Souza (ORCID: https://orcid.org/0000-0003-2524-4434)
- Victor Facchinetti (ORCID: https://orcid.org/0000-0001-8414-7197)
- Eliza de Lucas Chazin
- Emerson Lucena da Silva (ORCID: https://orcid.org/0000-0002-5761-8413)
- Breno Bernardes (ORCID: https://orcid.org/0009-0009-4229-3052)
- Cláudia R. B. Gomes
- M.V.N. De Souza (ORCID: https://orcid.org/0000-0003-1566-8110)
- Paula de Aquino Soeiro Portilho
Institutions
- Universidade Federal Fluminense (BR)
- Universidade Federal do Ceará (BR)
- Fundação Oswaldo Cruz (BR)
Publication Details
- Journal
- Current Topics in Medicinal Chemistry
- Published
- 2025-06-18
- DOI
- https://doi.org/10.2174/0115680266366285250528005320
- Primary Topic
- Synthesis and biological activity
- Type
- article
- Field-Weighted Citation Impact
- 0.00